Beam Therapeutics Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$222M
Industry:Biotech
Founded:2017
Lead Investor(s):Muliteple
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Beam Therapeutics's estimated annual revenue is currently $20.8M per year.
  • Beam Therapeutics received $135.0M in venture funding in March 2019.
  • Beam Therapeutics's estimated revenue per employee is $155,000
  • Beam Therapeutics's total funding is $222M.

Employee Data

  • Beam Therapeutics has 134 Employees.
  • Beam Therapeutics grew their employee count by 81% last year.
  • Beam Therapeutics currently has 4 job openings.

Executive Contacts

NameTitle
Elsie Zahr AkrawiPrincipal Research Associate
Francine GregoireVP Liver Diseases
Christine BellonChief Legal Officer
Bethany CavanaghVice President, FP&A
Suzanne FlemingSVP, Finance
Aaron EdwardsPrincipal Research Associate
Delai ChenAssociate Director
Dana LevasseurVice President, Hematology
Stephen CavnarDirector, New Product Planning
Sylvia EashDirector, Alliance Management & Business Development

Beam Therapeutics is developing precision genetic medicines for serious diseases. Co-founded by scientific pioneers known for advancing CRISPR gene editing, were the first company to pursue development of new therapies using CRISPR base editing technology. We aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. WHO WE ARE Beam is creating precision genetic medicines through base editing WHY WE DO IT Our dream is to provide life-long cures for patients suffering from serious diseases WHO WE ARE AND HOW WE WORK TOGETHER The Beam Team: A community of fearless innovators Rigorous and honest in our research Listening with open minds Committed to each other

keywords:N/A

134

Number of Employees

$20.8M

Revenue (est)

4

Current Jobs

81%

Employee Growth %

$222M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$7.1M4659%N/A
Tango Therapeut...
$9M5841%N/A
Compass Therape...
$15.8M10215%N/A
Emulate
$14.7M95-17%N/A
Hamilton Storag...
$14.6M949%N/A
Alnylam Pharmac...
$74.9M122831%N/A
Axcella
$8.8M5719%N/A
Berkshire Corpo...
$11.5M7412%N/A
Repligen Corpor...
$50.2M32422%N/A
Allena Pharmace...
$6M5019%N/A

Beam Therapeutics News

09/03/2019 - Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--. Beam Therapeutics, a biotechnology company developing precision genetic medicines through ...

09/08/2019 - Chutes & Ladders—Bausch Health's Salix loses McKenna to ...

LeSauteur comes out of the Human Health Therapeutics Research Center ... Cambridge, Massachusetts-based Beam Therapeutics has named ...

09/03/2019 - Growth of biopharma employment in Massachusetts

This year, Beam Therapeutics has been the largest beneficiary of venture capital, after raising $135m in its Series B financing round. However ...

Beam Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-05-15$87.0MAF-Prime Capital PartnersArticle
2019-03-07$135.0MBMulitepleArticle